As an established platform for purchasing unused diabetic supplies, we often receive inquiries about various products. Two that frequently come up are Trulicity and Wegovy.
Both of these injectable medications serve important purposes, but they cater to slightly different needs. So, let’s dive deeper and compare these two to give you a better understanding!
The Medications at a Glance
Trulicity, or Dulaglutide, is a once-weekly injectable medication that I regularly encounter. It’s primarily used alongside diet and exercise to control blood sugar levels in adults living with type 2 diabetes.
Trulicity also reduces the risk of major cardiovascular events like heart attack and stroke in people who have heart disease or multiple cardiovascular risk factors.
On the other hand, we have Wegovy or Semaglutide, another injectable prescription medicine, but it serves a different purpose. Wegovy is utilized by adults who are overweight or struggle with obesity and need to lose weight while keeping it off. It’s used in conjunction with a reduced-calorie meal plan and increased physical activity.
How They Work
Both Trulicity and Wegovy fall under the category of glucagon-like peptide-1 (GLP-1) receptor agonists. In simple terms, they help your body release its own insulin and reduce the amount of glucose released by your liver.
The difference lies in their effects. While Trulicity primarily works to manage blood sugar, Wegovy’s role is to reduce hunger, promoting feelings of fullness, and thus assisting with weight loss.
Dosage and Side Effects
When it comes to the dosage, both medications are injected subcutaneously once weekly. They’re similar in usage, but the side effects vary. For Trulicity, people might experience nausea, diarrhea, vomiting, abdominal pain, and decreased appetite.
Wegovy users, on the other hand, could face nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, and other gastrointestinal issues.
Every medication has its specifics. Trulicity isn’t intended for people with type 1 diabetes or diabetic ketoacidosis. Meanwhile, Wegovy should not be used with any other GLP-1 receptor agonist or other products aimed at weight loss.
Efficacy and Availability
Studies have consistently shown that Trulicity can effectively reduce A1C levels, the main indicator of long-term blood glucose control. Clinical trials of Wegovy have shown significant weight loss compared to a placebo.
Both Trulicity and Wegovy are typically covered by insurance, including Medicare and Medicaid, but the exact costs may vary depending on your plan. These are brand-name drugs, so the price without insurance can be high.
At the end of the day, it’s essential to remember that these medications, while promising, aren’t universal solutions. Each person is unique and requires personalized medical advice. That’s why we always advise consulting with a healthcare provider before starting any new medication.
Finally, if you have unused Trulicity or Wegovy that is not expired and properly stored, consider selling them to us.
By doing so, you not only receive compensation but also contribute to a chain of support, providing access to affordable supplies for those who need them. Contact us today for more information.